These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Three and one-half years' experience with a lower-dose combination oral contraceptive. Woutersz TB J Reprod Med; 1976 Jun; 16(6):338-44. PubMed ID: 957360 [TBL] [Abstract][Full Text] [Related]
4. Experience with a new low dose oral contraceptive: norgestimate & ethinyl estradiol. Rubio-Lotvin B; Gonzales-Ansorena R Acta Eur Fertil; 1978 Mar; 9(1):1-6. PubMed ID: 696184 [TBL] [Abstract][Full Text] [Related]
5. Clinical experience with a low-dose contraceptive agent. European studies. Haspels AA J Reprod Med; 1983 Jan; 28(1 Suppl):71-6. PubMed ID: 6403703 [TBL] [Abstract][Full Text] [Related]
6. Clinical trial of an oral contraceptive containing desogestrel and ethinyl estradiol. Weijers MJ Clin Ther; 1982; 4(5):359-66. PubMed ID: 6461412 [TBL] [Abstract][Full Text] [Related]
7. Oral contraception with a triphasic combination of gestodene and ethinyl estradiol: results of a multicenter clinical study. Skouby SO Int J Fertil; 1987; 32 Suppl():45-8. PubMed ID: 2906346 [TBL] [Abstract][Full Text] [Related]
8. Effectivity and acceptability of oral contraceptives containing natural and artificial estrogens in combination with a gestagen. A controlled double-blind investigation. Serup J; Bostofte E; Larsen S; Westergaard J Acta Obstet Gynecol Scand; 1981; 60(2):203-6. PubMed ID: 7018165 [TBL] [Abstract][Full Text] [Related]
9. Contraception with levonorgestrel, 0.15 mg, and ethinyl estradiol, 0.03 mg. Clinical studies in Latin America. Moggia AV J Reprod Med; 1983 Jan; 28(1 Suppl):77-80. PubMed ID: 6403704 [TBL] [Abstract][Full Text] [Related]
11. Five-year, multicenter study of a triphasic, low-dose, combination oral contraceptive. Woutersz TB; Korba VD Int J Fertil; 1988; 33(6):406-10. PubMed ID: 2906915 [TBL] [Abstract][Full Text] [Related]
12. Clinical and metabolic effects of gestodene and levonorgestrel. Rabe T; Runnebaum B; Kohlmeier M; Harenberg J; Weicker H Int J Fertil; 1987; 32 Suppl():29-44. PubMed ID: 2906345 [TBL] [Abstract][Full Text] [Related]
13. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives]. Cianci A; De Leo V Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832 [TBL] [Abstract][Full Text] [Related]
14. Profile of a new low dose combination estrogen and progestogen oral contraceptive: a review of nine clinical studies. Woutersz TB J Reprod Med; 1975 Sep; 15(3):87-92. PubMed ID: 1214254 [TBL] [Abstract][Full Text] [Related]
15. Multicenter randomized comparative trial of two low-dose triphasic combined oral contraceptives containing desogestrel or norethindrone. Shoupe D Obstet Gynecol; 1994 May; 83(5 Pt 1):679-85. PubMed ID: 8164925 [TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of a monophasic ethinylestradiol/desogestrel-containing oral contraceptive. Bilotta P; Favilli S Arzneimittelforschung; 1988 Jul; 38(7):932-4. PubMed ID: 2974702 [TBL] [Abstract][Full Text] [Related]
17. A multicenter clinical evaluation of a new monophasic combination: Minulet (gestodene and ethinyl estradiol). de Andrade RP Int J Fertil; 1989 Sep; 34 Suppl():22-30. PubMed ID: 2576253 [TBL] [Abstract][Full Text] [Related]